I have shared some inspiring stories with you of patients in my practice who I think are examples of how colon cancer therapies have changed. Today when patients walk into my practice with metastases only in liver or lungs, I know that I can cure some of them. The way we look at these patients has completely changed. Read the rest of this entry »
Thankful for Available Therapies in the USA
Since many of you know that I was trained in Germany, I have a surprising number of patients asking me if there are better therapies in Germany or in Europe than in the US.
Because of my role in clinical research and laboratory research I am invited to give lectures around the world about the latest in colon cancer research. In the last 12 months, I gave lectures in Japan, China, India, Germany, Spain, Portugal. Israel, Brazil, Argentina, Switzerland, and Greece. It is not easy to travel through so many time zones, but it is very important to understand different cultures and different ways that colon cancer patients are treated in Asia and Europe. The rest of the world is looking at us for what we do in colon cancer research. Read the rest of this entry »
Three-Point Rule Guides Which C-Diff Infections May Recur
About one in five patients with Clostridium difficile (C. difficile) infection will have that infection come back. Doctors have developed a simple, three-point rule that can help identify those patients most at risk for recurrence.
Patients who are most likely to have their infection return are over 65, have severe or suddenly intense symptoms, and continue other antibiotics after treatment for C. difficile infection.
Knowing which patients are likely to be in trouble can help doctors use interventions to prevent the disease from coming back, Read the rest of this entry »
Meet with your Representatives in your District!

C3 Advocate Marilia Sardinha with Senator Susan Collins (R-ME)
Meeting with your Member of Congress at home is an excellent opportunity to establish a relationship with your Representatives and their staff. Congress is currently in recess and will remain in their local districts until April 17th.
C3 encourages you to meet with your Representative and request their support and co-sponsorship of The Colorectal Cancer Prevention, Early Detection and Treatment Act (HR 1189). Our fact sheet will provide you with all of the information that you need in order to educate your Representative.
Call ahead and make an appointment or just drop by and ask if the Member is around and has some time to talk.
Arite Honored During Dialogue for Action

Joe Arite
C3 Director of Policy Joe Arite received the Cancer Prevention Laurel for Advocacy during a luncheon at the the national Dialogue for Action in Baltimore on April 2, 2009
The Prevent Cancer Foundation created the Cancer Prevention Laurel to recognize and celebrate innovators and leaders in the fight against colorectal cancer. Vince Papale, the former Philadelphia Eagles football player and a colorectal cancer survivor, presented the winners with their awards. Read the rest of this entry »


